Li et al. [2] further explored the action of sarsasapogenin in restoring podocyte autophagy in DN by targeting glycogen synthase kinase 3 beta pathway (GSK3β) signalling pathway. The gene discussed is GSK3B; the disease is liver dysplastic nodule.